Divalent Metal Ion Complexes of S100B in the Absence and Presence of Pentamidine

Journal of Molecular Biology

Volumn 382, Issue 1, 2008, Pages 56-73

  Charpentier, Thomas H ^a   Wilder, Paul T ^a   Liriano, Melissa A ^a   Varney, Kristen M ^a   Pozharski, Edwin ^b   MacKerell Jr , Alexander D ^b   Coop, Andrew ^b   Toth, Eric A ^a   Weber, David J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

calcium; pentamidine; S100B; X ray crystallography; zinc

Indexed keywords

CALCIUM; METAL ION; PENTAMIDINE; PROTEIN S100B; PROTEIN SUBUNIT; ZINC;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; DRUG PROTEIN BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

EID: 49349090104     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.06.047     Document Type: Article

References (81)

1. Moore B. A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 19 (1965) 739-744
2. Weber D.J., Rustandi R.R., Carrier F., and Zimmer D.B. Interaction of dimeric S100B(ββ) with the tumor suppressor protein: a model for Ca-dependent S100-target protein interactions. In: Pochet R. (Ed). The Molecular Basis of Calcium Action in Biology and Medicine (2000), Kluwer Academic Publishers, Dordrecht, The Netherlands
3. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60 (2003) 540-551
4. Heizmann C.W. The multifunctional S100 protein family. Methods Mol. Biol. 172 (2002) 69-80
5. Santamaria-Kisiel L., Rintala-Dempsey A.C., and Shaw G.S. Calcium-dependent and -independent interactions of the S100 protein family. Biochem. J. 396 (2006) 201-214
6. 2+-dependent interaction of S100B with a peptide derived from p53. Biochemistry 37 (1998) 1951-1960
7. Wilder P.T., Baldisseri D.M., Udan R., Vallely K.M., and Weber D.J. Location of the Zn(2+)-binding site on S100B as determined by NMR spectroscopy and site-directed mutagenesis. Biochemistry 42 (2003) 13410-13421
8. Wilder P.T., Varney K.M., Weiss M.B., Gitti R.K., and Weber D.J. Solution structure of zinc- and calcium-bound rat S100B as determined by nuclear magnetic resonance spectroscopy. Biochemistry 44 (2005) 5690-5702
9. Baudier J., and Gerard D. Ions binding to S100 proteins: structural changes induced by calcium and zinc on S100a and S100b proteins. Biochemistry 22 (1983) 3360-3369
10. 2+ binding on S100b protein. J. Biol. Chem. 261 (1986) 8192-8203
11. Baudier J., Haglid K., Haiech J., and Gerard D. Zinc ion binding to human brain calcium binding proteins, calmodulin and S100b protein. Biochem. Biophys. Res. Commun. 114 (1983) 1138-1146
12. Deloulme J.C., Assard N., Mbele G.O., Mangin C., Kuwano R., and Baudier J. S100A6 and S100A11 are specific targets of the calcium- and zinc-binding S100B protein in vivo. J. Biol. Chem. 275 (2000) 35302-35310
13. 2+ enhancement of the S100B binding epitope TRTK-12. J. Biol. Chem. 274 (1999) 1502-1508
14. 2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 263 (1988) 5876-5883
15. 2+ homeostasis regulation by S100B. J. Biol. Chem. 276 (2001) 23253-23261
16. Zimmer D.B., Cornwall E.H., Landar A., and Song W. The S100 protein family: history, function, and expression. Brain Res. Bull. 37 (1995) 417-429
17. Hansson L.O., Vonschoultz E., Djureen E., Hansson J., Nilsson B., and Ringborg U. Prognostic value of serum analyses of S100 protein beta in malignant melanoma. Anticancer Res. 17 (1997) 3071-3073
18. Maelandsmo G.M., Florenes V.A., Mellingsaeter T., Hovig E., Kerbel R.S., and Fodstad O. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int. J. Cancer 74 (1997) 464-469
19. 2+-binding proteins S100A6 and S100B in primary cutaneous melanoma. J. Cutaneous Pathol. 24 (1997) 76-80
20. Camby I., Lefranc F., Titeca G., Neuci S., Fastrez M., Dedecken L., et al. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours. Neuropathol. Appl. Neurobiol. 26 (2000) 76-90
21. Camby I., Nagy N., Lopes M.B., Schafer B.W., Maurage C.A., Ruchoux M.M., et al. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol. 9 (1999) 1-19
22. 2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells. J. Biol. Chem. 276 (2001) 30819-30826
23. Hauschild A., Engel G., Brenner W., Glaser R., Monig H., Henze E., and Christophers E. Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy. Br. J. Dermatol. 140 (1999) 1065-1071
24. Hauschild A., Engel G., Brenner W., Glaser R., Monig H., Henze E., and Christophers E. S100B protein detection in serum is a significant prognostic factor in metastatic melanoma. Oncology 56 (1999) 338-344
25. Hauschild A., Michaelsen J., Brenner W., Rudolph P., Glaser R., Henze E., and Christophers E. Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients. Melanoma Res. 9 (1999) 155-161
26. Baudier J., Delphin C., Grunwald D., Khochbin S., and Lawrence J.J. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and an S100b-binding protein. Proc. Natl Acad. Sci. USA 89 (1992) 11627-11631
27. Rustandi R.R., Baldisseri D.M., and Weber D.J. Structure of the negative regulatory domain of p53 bound to S100B. Nat. Struct. Biol. 7 (2000) 570-574
28. Delphin C., Ronjat M., Deloulme J.C., Garin G., Debussche L., Higashimoto Y., et al. Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53. J. Biol. Chem. 274 (1999) 10539-10544
29. Lin J., Yang Q., Yan Z., Markowitz J., Wilder P.T., Carrier F., and Weber D.J. Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells. J. Biol. Chem. 279 (2004) 34071-34077
30. Wilder P.T., Lin J., Bair C.L., Charpentier T.H., Yang D., Liriano M., et al. Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B. Biochim. Biophys. Acta 1763 (2006) 1284-1297
31. Markowitz J., Chen I., Gitti R., Baldisseri D.M., Pan Y., Udan R., et al. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction. J. Med. Chem. 47 (2004) 5085-5093
32. Markowitz J., Mackerell Jr. A.D., Carrier F., Charpentier T.H., and Weber D.J. Design of inhibitors for S100B. Curr. Top. Med. Chem. 5 (2005) 1093-1108
33. Markowitz J., MacKerell Jr. A.D., and Weber D.J. A search for inhibitors of S100B, a member of the S100 family of calcium-binding proteins. Mini Rev. Med. Chem. 7 (2007) 609-616
34. Borovansky J., Riley P.A., Vrankova E., and Necas E. The effect of zinc on mouse melanoma growth in vitro and in vivo. Neoplasma 32 (1985) 401-406
35. Gorodetsky R., Sheskin J., and Weinreb A. Iron, copper, and zinc concentrations in normal skin and in various nonmalignant and malignant lesions. Int. J. Dermatol. 25 (1986) 440-445
36. Ros-Bullon M.R., Sanchez-Pedreno P., and Martinez-Liarte J.H. Serum zinc levels are increased in melanoma patients. Melanoma Res. 8 (1998) 273-277
37. Prasad K.N., Ahrens C.R., and Barrett J.M. Homeostasis of zinc and iron in mouse B16 melanoma. Cancer Res. 29 (1969) 1019-1023
38. Lin J., Blake M., Tang C., Zimmer D., Rustandi R.R., Weber D.J., and Carrier F. Inhibition of p53 transcriptional activity by the S100B calcium-binding protein. J. Biol. Chem. 276 (2001) 35037-35041
39. Wilson D., Varigos G., and Ackland M.L. Apoptosis may underlie the pathology of zinc-deficient skin. Immunol. Cell Biol. 84 (2006) 28-37
40. Velazquez-Campoy A., Todd M.J., and Freire E. HIV-1 protease inhibitors: enthalpic versus entropic optimization of the binding affinity. Biochemistry 39 (2000) 2201-2207
41. Jelesarov I., and Bosshard H.R. Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition. J. Mol. Recognit. 12 (1999) 3-18
42. Meyer B., Klein J., Mayer M., Meinecke R., Moller H., Neffe A., et al. Saturation transfer difference NMR spectroscopy for identifying ligand epitopes and binding specificities. Ernst Schering Res. Found. Workshop 44 (2004) 149-167
43. Drohat A.C., Baldisseri D.M., Rustandi R.R., and Weber D.J. Solution structure of calcium-bound rat S100B as determined by nuclear magnetic resonance spectroscopy. Biochemistry 37 (1998) 2729-2740
44. Matsumura H., Shiba T., Inoue T., Harada S., and Kai Y. A novel mode of target recognition suggested by the 2.0 Å structure of holo S100B from bovine brain. Structure 6 (1998) 233-241
45. Otterbein L.R., Kordowska J., Witte-Hoffmann C., Wang C.L., and Dominguez R. Crystal structures of S100A6 in the Ca(2+)-free and Ca(2+)-bound states: the calcium sensor mechanism of S100 proteins revealed at atomic resolution. Structure 10 (2002) 557-567
46. 2+-free states. Biochemistry 38 (1999) 1695-1704
47. Heizmann C.W., and Cox J.A. New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family. BioMetals 11 (1998) 383-397
48. Yan J., Kline A.D., Mo H., Shapiro M.J., and Zartler E.R. The effect of relaxation on the epitope mapping by saturation transfer difference NMR. J. Magn. Reson. 163 (2003) 270-276
49. Burley S.K., and Petsko G.A. Aromatic-aromatic interaction: a mechanism of protein structure stabilization. Science 229 (1985) 23-28
50. Moroz O.V., Antson A.A., Grist S.J., Maitland N.J., Dodson G.G., Wilson K.S., et al. Structure of the human S100A12-copper complex: implications for host-parasite defence. Acta Crystallogr., Sect. D: Biol. Crystallogr. 59 (2003) 859-867
51. Moroz O.V., Dodson G.G., Wilson K.S., Lukanidin E., and Bronstein I.B. Multiple structural states of S100A12: a key to its functional diversity. Microsc. Res. Tech. 60 (2003) 581-592
52. 2+-binding proteins. Eur. J. Biochem. 249 (1997) 127-133
53. 2+ to human nuclear S100A2 and mutant proteins. J. Biol. Chem. 273 (1998) 18826-18834
54. Fohr U.G., Heizmann C.W., Engelkamp D., Schafer B.W., and Cox J.A. Purification and cation binding properties of the recombinant human S100 calcium-binding protein A3, an EF-hand motif protein with high affinity for zinc. J. Biol. Chem. 270 (1995) 21056-21061
55. Schafer B.W., Fritschy J.M., Murmann P., Troxler H., Durussel I., Heizmann C.W., and Cox J.A. Brain S100A5 is a novel calcium-, zinc-, and copper ion-binding protein of the EF-hand superfamily. J. Biol. Chem. 275 (2000) 30623-30630
56. 2+ bind to different sites and induce different conformational changes in human calcyclin. Eur. J. Biochem. 253 (1998) 57-66
57. Pedrocchi M., Schafer B.W., Durussel I., Cox J.A., and Heizmann C.W. Purification and characterization of the recombinant human calcium-binding S100 proteins CAPL and CACY. Biochemistry 33 (1994) 6732-6738
58. 2+-switch model. J. Mol. Biol. 283 (1998) 679-694
59. Korndorfer I.P., Brueckner F., and Skerra A. The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins. J. Mol. Biol. 370 (2007) 887-898
60. Lee K.C., and Eckert R.L. S100A7 (psoriasin)-mechanism of antibacterial action in wounds. J. Invest. Dermatol. 127 (2007) 945-957
61. Glaser R., Harder J., Lange H., Bartels J., Christophers E., and Schroder J.M. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat. Immunol. 6 (2005) 57-64
62. Christianson D.W. Structural biology of zinc. Adv. Protein Chem. 42 (1991) 281-355
63. Vallee B.L., and Auld D.S. Cocatalytic zinc motifs in enzyme catalysis. Proc. Natl Acad. Sci. USA 90 (1993) 2715-2718
64. Inman K.G., Yang R., Rustandi R.R., Miller K.E., Baldisseri D.M., and Weber D.J. Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12. J. Mol. Biol. 324 (2002) 1003-1014
65. Mori S., Abeygunawardana C., Johnson M.O., and van Zijl P.C. Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J. Magn. Reson., Ser. B 108 (1995) 94-98
66. Mayer M., and Meyer B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123 (2001) 6108-6117
67. Bax A., and Davis D.G. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 63 (1985) 207-213
68. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
69. Edison A.S., Abildgaard F., Westler W.M., Mooberry E.S., and Markley J.L. Practical introduction to theory and implementation of multinuclear, multidimensional nuclear magnetic resonance experiments. Methods Enzymol. 239 (1994) 3-79
70. 15N NMR study of gramicidin S in water and organic solvents. J. Am. Chem. Soc. 106 (1984) 1939-1941
71. Spera S., and Bax A. Empirical correlation between protein backbone conformation and Ca and Cb/13-C nuclear magnetic resonance chemical shifts. J. Am. Chem. Soc. 113 (1991) 5490-5492
72. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
73. Vagin A.A., and Isupov M.N. Spherically averaged phased translation function and its application to the search for molecules and fragments in electron-density maps. Acta Crystallogr., Sect. D: Biol. Crystallogr. 57 (2001) 1451-1456
74. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr., Sect. D: Biol. Crystallogr. 53 (1997) 240-255
75. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 (2004) 2126-2132
76. Laskowski R.A., MacArthur M.W., Moss D.S., and Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26 (1993) 283-291
77. Laskowski R.A., MacArthur M.W., and Thornton J.M. Validation of protein models derived from experiment. Curr. Opin. Struct. Biol. 8 (1998) 631-639
78. Yap K.L., Ames J.B., Swindells M.B., and Ikura M. Diversity of conformational states and changes within the EF-hand protein superfamily. Proteins: Struct. Funct. Genet. 37 (1999) 499-507
79. Gagné S.M., Tsuda S., Li M.X., Smillie L.B., and Sykes B.D. Structures of the troponin C regulatory domains in the apo and calcium-saturated states. Nat. Struct. Biol. 2 (1995) 784-789
80. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., et al. The Protein Data Bank. Nucleic Acids Res. 28 (2000) 235-242
81. Yang H., Guranovic V., Dutta S., Feng Z., Berman H.M., and Westbrook J.D. Automated and accurate deposition of structures solved by X-ray diffraction to the Protein Data Bank. Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 (2004) 1833-1839